Intracranial arteriovenous malformations

Prog Brain Res. 2022;268(1):75-97. doi: 10.1016/bs.pbr.2021.10.027. Epub 2022 Jan 13.


The treatment of arteriovenous malformations (AVMs) has evolved over the last 10 years. It is now possible to see that obliteration continues for up to 10 years and that the final obliteration rate may be between 85% and 90%. Improved imaging has made the treatment more efficient and has reduced the complications. It is possible to treat larger AVMs in a single session than was previously thought possible without increases in the complication rates. In addition, treatments of larger lesions can be staged. The use of 3D rotating angiography produces remarkable images which can be imported into GammaPlan. On the other hand efforts are ongoing to avoid the need for digital subtraction angiography, which would make the treatment a lot more comfortable.

Keywords: ARUBA; Adverse radiation effects; Arteriovenous malformation; Assessment scales; Digital subtraction angiography; Expansive hematoma; Late cyst formation; Obliteration; Radionecrosis; Staged radiosurgery.

MeSH terms

  • Follow-Up Studies
  • Humans
  • Intracranial Arteriovenous Malformations* / complications
  • Intracranial Arteriovenous Malformations* / diagnostic imaging
  • Intracranial Arteriovenous Malformations* / therapy
  • Radiosurgery* / methods
  • Treatment Outcome